LENZ Therapeutics's market cap is currently ―. The company's EPS TTM is $-15.336; its P/E ratio is -1.07; LENZ Therapeutics is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.82. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -22.92M	$ -22.48M	$ -55.31M	$ -23.93M	$ -24.60M
EBITDA	$ -17.81M	-	$ -55.37M	$ -24.84M	$ -25.04M
Net Income Common Stockholders	$ -22.92M	$ -22.48M	$ -55.31M	$ -23.93M	$ -24.60M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 184.26M	$ 233.99M	$ 246.66M	$ 264.10M	$ 268.23M
Total Assets	$ 188.46M	$ 266.23M	$ 287.02M	$ 310.00M	$ 321.90M
Total Debt	$ 362.00K	$ 53.10M	$ 53.50M	$ 4.50M	$ 5.79M
Net Debt	$ -183.90M	$ -180.89M	$ -193.16M	$ -259.60M	$ -262.44M
Total Liabilities	$ 4.87M	$ 62.21M	$ 62.86M	$ 33.77M	$ 25.61M
Stockholders Equity	$ 183.58M	$ 204.02M	$ 224.10M	$ 276.22M	$ 296.29M
Cash Flow	-
Free Cash Flow	$ -45.25M	-	$ -18.93M	$ -21.46M	$ -23.47M
Operating Cash Flow	$ -45.88M	$ -9.40M	$ -13.65M	$ -21.07M	$ -22.45M
Investing Cash Flow	$ 47.08M	$ 63.88M	$ 72.23M	$ 43.16M	$ 13.52M
Financing Cash Flow	$ 66.00K	$ 8.00K	$ 124.00K	$ -8.00K	$ 244.00K

Currency in USD

LENZ Therapeutics Earnings and Revenue History

Income Statement >

LENZ Therapeutics Debt to Assets

Balance Sheet >

LENZ Therapeutics Cash Flow

Cash Flow >

LENZ Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing